A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Completed · Phase 1

Conditions studied: Asthma, Healthy Subjects or Volunteers

In brief

The primary objective of this study is to evaluate the pharmacokinetics (PK) and tolerability of tralokinumab when delivered subcutaneously at different flow rates to healthy volunteers.

Key facts

Study ID

NCT02085473

Run by

MedImmune LLC

People needed

60

Starts

2014-03-19

Expected to finish

2014-07-10

Last updated by the study team

2018-12-31

Who can join

Age: 19 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Where it is running

• Celerion — Lincoln, Nebraska, United States
• Research Site — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.